114 related articles for article (PubMed ID: 1602380)
1. Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
Sun XY; Edvinsson L; Hedner T
J Pharmacol Exp Ther; 1992 Jun; 261(3):1147-52. PubMed ID: 1602380
[TBL] [Abstract][Full Text] [Related]
2. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
Bell D; Millar BC; McDermott BJ
Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
[TBL] [Abstract][Full Text] [Related]
3. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
Sun XY; Dahlöf C; Edvinsson L; Hedner T
Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
[TBL] [Abstract][Full Text] [Related]
4. Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
Sun XY; Edvinsson L; Yoo H; Wahlestedt C; Hedner T
J Cardiovasc Pharmacol; 1995 May; 25(5):696-704. PubMed ID: 7630147
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Sun X; Edvinsson L; Hedner T
J Hypertens; 1993 Sep; 11(9):935-43. PubMed ID: 8254175
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
Aubert JF; Waeber B; Rossier B; Geering K; Nussberger J; Brunner HR
J Pharmacol Exp Ther; 1988 Sep; 246(3):1088-92. PubMed ID: 2843627
[TBL] [Abstract][Full Text] [Related]
7. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
Ralevic V; Edvinsson L; Burnstock G
Acta Physiol Scand; 1994 Jul; 151(3):309-17. PubMed ID: 7976403
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuropeptide Y-induced potentiation of noradrenaline-induced vasoconstriction by PP56 (D-myo-inositol 1,2,6-tris-phosphate).
Adamsson M; Fallgren B; Edvinsson L
Br J Pharmacol; 1992 Jan; 105(1):93-6. PubMed ID: 1596693
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56).
Sun XY; Edvinsson L; Hedner T
J Hypertens Suppl; 1991 Dec; 9(6):S344-5. PubMed ID: 1818993
[No Abstract] [Full Text] [Related]
11. Antagonistic effect of D-myo-inositol-1,2,6-trisphosphate (PP56) on neuropeptide Y-induced vasoconstriction in the feline dental pulp.
Kim SK; Ang L; Hsu YY; Dörscher-Kim J; Kim S
Arch Oral Biol; 1996; 41(8-9):791-8. PubMed ID: 9022916
[TBL] [Abstract][Full Text] [Related]
12. D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y.
Schwieler JH; Hjemdahl P
J Cardiovasc Pharmacol; 1993 Mar; 21(3):347-52. PubMed ID: 7681493
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
[TBL] [Abstract][Full Text] [Related]
14. Effects of intracerebroventricular D-myo-inositol-1,2,6-trisphosphate (PP56), a proposed neuropeptide Y (NPY) antagonist, on locomotor activity, food intake, central effects of NPY and NPY-receptor binding.
Heilig M; Edvinsson L; Wahlestedt C
Eur J Pharmacol; 1991 Dec; 209(1-2):27-32. PubMed ID: 1667639
[TBL] [Abstract][Full Text] [Related]
15. Role of neuropeptide Y (NPY) in cardiovascular responses to stress.
Zukowska-Grojec Z; Vaz AC
Synapse; 1988; 2(3):293-8. PubMed ID: 3212674
[TBL] [Abstract][Full Text] [Related]
16. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
Bischoff A; Stickan-Verfürth M; Michel MC
Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
18. Blockade of neuropeptide Y-induced potentiation of noradrenaline-evoked vasoconstriction by D-myo-inositol-1.2.6-trisphosphate (PP56) in rabbit femoral arteries.
Adamsson M; Edvinsson L
Neuropeptides; 1991 May; 19(1):13-6. PubMed ID: 1891070
[TBL] [Abstract][Full Text] [Related]
19. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
20. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]